| 000 | 01785 a2200481 4500 | ||
|---|---|---|---|
| 005 | 20250517160619.0 | ||
| 264 | 0 | _c20180530 | |
| 008 | 201805s 0 0 eng d | ||
| 022 | _a1552-4604 | ||
| 024 | 7 |
_a10.1002/jcph.947 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aFowler, Andy | |
| 245 | 0 | 0 |
_aSafety, Tolerability, Pharmacokinetics, and Pharmacodynamics of the Novel CRTH2 Antagonist BI 1021958 at Single Oral Doses in Healthy Men and Multiple Oral Doses in Men and Women With Well-Controlled Asthma. _h[electronic resource] |
| 260 |
_bJournal of clinical pharmacology _cNov 2017 |
||
| 300 |
_a1444-1453 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial, Phase I; Journal Article; Randomized Controlled Trial | ||
| 650 | 0 | 4 | _aAdministration, Oral |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aAnti-Asthmatic Agents _xadverse effects |
| 650 | 0 | 4 | _aArea Under Curve |
| 650 | 0 | 4 |
_aAsthma _xdrug therapy |
| 650 | 0 | 4 | _aCross-Over Studies |
| 650 | 0 | 4 | _aDose-Response Relationship, Drug |
| 650 | 0 | 4 | _aDouble-Blind Method |
| 650 | 0 | 4 |
_aEosinophils _xdrug effects |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aFood-Drug Interactions _xphysiology |
| 650 | 0 | 4 | _aHalf-Life |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aReceptors, Immunologic _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aReceptors, Prostaglandin _xantagonists & inhibitors |
| 650 | 0 | 4 | _aSingle-Blind Method |
| 700 | 1 | _aKoenen, Rüdiger | |
| 700 | 1 | _aHilbert, James | |
| 700 | 1 | _aBlatchford, Jon | |
| 700 | 1 | _aKappeler, Dominik | |
| 700 | 1 | _aBenediktus, Ewald | |
| 700 | 1 | _aWood, Chester | |
| 700 | 1 | _aGupta, Abhya | |
| 773 | 0 |
_tJournal of clinical pharmacology _gvol. 57 _gno. 11 _gp. 1444-1453 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1002/jcph.947 _zAvailable from publisher's website |
| 999 |
_c27272966 _d27272966 |
||